Burning Rock Announces Plan to Pursue An Alternative Listing
June 21, 2022 01:59 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports First Quarter 2022 Financial Results
May 31, 2022 02:32 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, May 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
May 16, 2022 04:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
March 21, 2022 20:30 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Secures Second NGS Kit Approval from the NMPA
March 15, 2022 09:38 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that the National Medical Products Administration...
Burning Rock to Release MRD Clinical Data on NSCLC and CRC at the Upcoming American Association for Cancer Research Annual Meeting
March 15, 2022 07:29 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it will present MRD (molecular residual disease)...
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022
February 21, 2022 23:30 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 Million
December 28, 2021 20:05 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the...
Burning Rock Announces Results of 2021 Annual General Meeting
December 27, 2021 22:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Burning Rock’s OncoCompass Target™
November 17, 2021 20:15 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Merck KGaA, Darmstadt,...